Cargando…
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
BACKGROUND: Breast cancer circulating biomarkers include carcinoembryonic antigen and carbohydrate antigen 15–3, which are used for patient follow-up. Since sensitivity and specificity are low, novel and more useful biomarkers are needed. The presence of stable circulating microRNAs (miRNAs) in seru...
Autores principales: | Mangolini, Alessandra, Ferracin, Manuela, Zanzi, Maria Vittoria, Saccenti, Elena, Ebnaof, Sayda Omer, Poma, Valentina Vultaggio, Sanz, Juana M., Passaro, Angela, Pedriali, Massimo, Frassoldati, Antonio, Querzoli, Patrizia, Sabbioni, Silvia, Carcoforo, Paolo, Hollingsworth, Alan, Negrini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483205/ https://www.ncbi.nlm.nih.gov/pubmed/26120471 http://dx.doi.org/10.1186/s40364-015-0037-0 |
Ejemplares similares
-
Absolute quantification of cell-free microRNAs in cancer patients
por: Ferracin, Manuela, et al.
Publicado: (2015) -
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
por: Lupini, Laura, et al.
Publicado: (2018) -
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression
por: Ferracin, Manuela, et al.
Publicado: (2013) -
Metastatic syringoid eccrine carcinoma of the nipple
por: Ballardini, Pierluigi, et al.
Publicado: (2012) -
GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature
por: Querzoli, Patrizia, et al.
Publicado: (2021)